Femara (Letrozole)

Femara (Letrozole) – Patient Information for Australia

Basic Product Information

Mechanism of Action

• For Patients: Femara (letrozole) works by reducing the amount of oestrogen your body makes. Many breast cancers require oestrogen to grow, so by lowering oestrogen, Femara helps to slow or stop the growth of these cancers.
• For Clinicians: Letrozole is a non-steroidal aromatase inhibitor. It selectively inhibits aromatase, the enzyme that catalyses the conversion of androgens to oestrogens in peripheral tissues, thus significantly lowering circulating oestrogen levels. This action is crucial in hormone receptor-positive postmenopausal breast cancer.

Pharmacokinetics

• Absorption: Letrozole is rapidly and completely absorbed from the gastrointestinal tract following oral administration. Peak plasma concentrations are reached within approximately 1 hour (T_max ~ 1 hour).
• Metabolism: It is extensively metabolised in the liver via cytochrome P450 isoenzymes, mainly CYP3A4 and CYP2A6, to an inactive carbinol metabolite.
• Elimination: Mostly excreted via the kidneys (about 90%) as metabolites; only a small proportion is eliminated unchanged. The elimination half-life is approximately 2 days.
• Duration of Action: Once-daily dosing maintains steady plasma levels.

Use in Everyday Life and Best Practices

Femara is usually taken once daily, at around the same time each day, with or without food. For Australian patients, incorporating medication into a daily routine (such as breakfast or bedtime) aids adherence. Consistency supports the best therapeutic results.

• Typically used in postmenopausal women for their type of breast cancer (oestrogen receptor-positive).
• Femara should only be used under medical supervision.
• Always follow your oncologist’s directions.
• Swallow tablet whole with a full glass of water; do not crush or chew.
• Keep medicines out of reach of children and store at room temperature away from moisture and heat.

Dosing in the Morning vs Evening

• No clear difference in efficacy between taking Femara in the morning or evening.
• Advantages of Morning Dosing: Easier to remember, less likely to interfere with sleep if mild insomnia occurs.
• Advantages of Evening Dosing: May reduce awareness of side effects like dizziness or fatigue during waking hours.
• Most important is consistency—take Femara around the same time each day.
• Consider individual lifestyle and preferences. If experiencing side effects, discuss with your healthcare provider about timing adjustments.

Taking with Food or on an Empty Stomach

• Letrozole may be taken with or without food.
• Food does not significantly affect absorption or efficacy.
• If you experience nausea, taking Femara with a light meal (e.g., toast or a sandwich) may help.
• Australian dietary habits (such as breakfast cereals, breads, or fruit) are suitable when taking this medication.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Always confirm dose with your prescribing doctor, as they will tailor your dose to your condition and personal circumstances.

Safety Profile and Side Effects

• Warnings: Let your doctor know if you have liver or kidney disease, osteoporosis, or are pregnant/planning pregnancy. Not for use in premenopausal women except under specialist care.
• If you experience severe or unusual symptoms, such as swelling, shortness of breath, yellow skin/eyes, severe pain, or allergic reactions, seek immediate medical attention.

Guidelines for Proper Use (Australia-specific advice)

• Always take Femara exactly as prescribed.
• Renew your script before you run out—PBS scripts can be repeated at your community pharmacy.
• Arrange regular follow-up with your oncologist or GP as recommended.
• Annual bone density checks may be advised, as Femara can lower bone strength.
• Maintain a healthy diet rich in calcium and vitamin D (common in Australian recommendations: low-fat dairy, leafy greens, fish).
• Stay active—regular exercise supports bone health and general wellbeing.
• Report persistent side effects or sudden changes to your pharmacist or doctor.
• Store tablets in a cool, dry place – typical Australian household conditions are fine.

Alternative Treatment Options

• Other Aromatase Inhibitors: Anastrozole (Arimidex®), exemestane (Aromasin®) – Similar efficacy and PBS reimbursed.
• Selective Oestrogen Receptor Modulator: Tamoxifen – Suitable for pre- and postmenopausal women.
• Pros: Some alternatives may be better tolerated if side effects occur, or may be chosen for specific patient profiles.
• Cons: Letrozole may be preferred in certain subtypes or after other medicines. Switching between agents should only be done under specialist supervision.

All medicines above are available via the PBS (Pharmaceutical Benefits Scheme), making them accessible and affordable for most Australian patients.

Legal, Registration, and Reimbursement Status in Australia

• Registered with the Therapeutic Goods Administration (TGA) for the treatment of oestrogen receptor-positive breast cancer.
• Prescription-only medicine (Schedule 4: S4) under the Poisons Standard.
• Subsidised via PBS (Pharmaceutical Benefits Scheme) for listed indications.
• Off-label uses (e.g. infertility) are not PBS-subsidised and must be individually justified.
• Use in clinical trials or new indications is subject to TGA and local ethics approval.

Latest Research and Clinical Guidance (2022–2025)

• Latest evidence supports the continued use of letrozole as first-line adjuvant and extended adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive early breast cancer (Cancer Council Australia Guidelines, updated 2023).
• Australian experts recommend regular review of bone health and cardiovascular risk factors for patients on long-term letrozole (Society of Breast Disease, 2023–2024).
• Clinical guidelines recommend considering switching between aromatase inhibitors or to tamoxifen if side effects are a barrier (eviQ Cancer Treatments Online, 2024 update).
• Overseas studies (NEJM, 2023) confirm letrozole’s equivalence or superiority in recurrence-free survival compared to other aromatase inhibitors.

Availability and Delivery in Australia

Letrozole/Femara is widely stocked in Australian pharmacies. Always order ahead if you are living in a rural or regional location, especially during public holidays.

Frequently Asked Questions (FAQ)

• Can Femara be used in premenopausal women?
  No, Femara is generally for postmenopausal women. In rare cases, fertility specialists may prescribe it for ovulation induction under strict supervision.
• What should I do if I miss a dose?
  If you remember within 12 hours of the scheduled time, take the missed dose as soon as possible. If more than 12 hours have passed, skip the missed dose and continue with your regular schedule. Do not double up to make up for a missed tablet.
• How long will I need to take Femara?
  Duration of treatment varies; commonly taken for 5 years, sometimes longer. Your doctor will advise based on your cancer type, risk, and tolerance.
• Will Femara affect my bones?
  Letrozole may lower bone density. Regular bone scans and supplementation with calcium/vitamin D may be recommended. Maintain a healthy diet and active lifestyle.
• Can I drive or use machinery on Femara?
  Letrozole can occasionally cause fatigue or dizziness. If you experience these symptoms, use caution when driving or operating machinery.